Craft

Yisheng Biopharma

Stock Price

$0.4

2024-02-28

Market Capitalization

$72.5 M

2024-02-28

Revenue

¥687.2 M

FY, 2023

Yisheng Biopharma Summary

Company Summary

Overview
Yisheng Biopharma (辽宁依生生物制药有限公司, also known as YS Biopharma) is a company engaged in development, production, marketing and sale of vaccines and therapeutic biologics for infectious diseases and cancer. Its products include PIKA® immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Shingles, Influenza, Coronavirus.
Type
Public
Status
Active
Founded
2002
HQ
Beijing, CN | view all locations
Website
https://www.ysbiopharm.com/
Cybersecurity rating
Sectors

Key People

  • Yi Zhang

    Yi Zhang, Founder & Chairman

    • David (Hui) Shao

      David (Hui) Shao, President and CEO

    • Brenda Wu

      Brenda Wu, Chief Financial Officer

      • Zenaida Mojares

        Zenaida Mojares, Chief Medical Officer

        LocationsView all

        2 locations detected

        • Beijing, Bei Jing Shi HQ

          China

          Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District

        • Gaithersburg, MD

          United States

          11 Firstfield Rd Suite A

        Yisheng Biopharma Financials

        Summary Financials

        Revenue (Q2, 2024)
        ¥96.8M
        Gross profit (Q2, 2024)
        ¥99.2M
        Net income (Q2, 2024)
        (¥105.0M)
        Cash (Q2, 2024)
        ¥259.9M
        EBIT (Q2, 2024)
        (¥100.4M)
        Enterprise value
        $365.6M

        News

        Footer menu